Australia markets closed

Opyl Limited (OPL.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.0380+0.0030 (+8.57%)
At close: 02:40PM AEST

Opyl Limited

Engine House
105 Wellington Street
St Kilda, VIC 3182
Australia
61 3 9923 1222
https://www.opyl.ai

Sector(s)Healthcare
IndustryHealth Information Services
Full-time employees

Key executives

NameTitlePayExercisedYear born
Ms. Michelle GallaherChief Exec. Officer278.48kN/AN/A
Mr. Damon RasheedExec. Director55.24kN/AN/A
Mr. Shane LewisVP of Sales & PartnershipsN/AN/AN/A
Mr. Scott SorochakChief Revenue OfficerN/AN/AN/A
Mr. Jason WeaverChief Product Officer & AdvisorN/AN/AN/A
Mr. David Iilja M.B.A.Company Sec.N/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Opyl Limited develops digital tools that improves healthcare experience for patients in Australia. It also offers Opin, a clinical trial recruitment platform that leverages social media, search engine optimization technologies and emerging artificial intelligence science, and matching patients directly to clinical trials; and social media marketing agency services, such as client and account management services for pharmaceutical, medtech, and biotech industries. The company was formerly known as ShareRoot Limited and changed its name to Opyl Limited in December 2019. Opyl Limited was incorporated in 1994 and is based in St Kilda, Australia.

Corporate governance

Opyl Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.